Regeneron Pharmaceuticals Surges to 88th in Trading Volume with $799 Million in Shares Exchanged

On March 26, 2025, Regeneron Pharmaceuticals Inc. (REGN) saw a significant surge in trading volume, with a total of $799 million in shares exchanged, marking a 46.05% increase from the previous day. This surge placed Regeneron at the 88th position in terms of trading volume for the day, highlighting a notable level of investor interest and activity.

Regeneron Pharmaceuticals Inc. has announced that it will release its first-quarter 2025 earnings report on Tuesday, April 29, 2025, before the U.S. markets open. This upcoming financial report is highly anticipated as it will provide insights into the company's performance and strategic direction for the year ahead.

In its latest financial update, Regeneron Pharmaceuticals reported a net margin of 31.07% and a return on equity of 16.32%. The company's revenue for the quarter showed a 10.3% increase compared to the same period last year, indicating strong financial health and growth potential.

Regeneron Pharmaceuticals, Inc. reported earnings per share of $12.07 for the quarter, surpassing analysts' consensus estimates of $11.21 by $0.86. This positive earnings surprise reflects the company's robust financial performance and effective management strategies.